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Abstract: 
 
Alzheimer's disease is a chronic illness characterized by clinical cognitive impairment. A 
behavioral strategy that is being explored in the prevention of Alzheimer's disease is physical 
activity. Evidence from randomized controlled trials (RCTs) testing the effects of physical 
activity for cognitively normal older adults supports that physical activity benefits cognitive 
performance. Evidence from prospective studies supports a protective effect of physical activity 
with reductions in the risk of cognitive decline ranging from 28% to 45%. RCTs with cognitively 
impaired older adults also generally support positive effects with greater benefits evident for 
aerobic interventions. Research examining the potential moderating role of apolipoprotein E 
(APOE) has yielded mixed results, but the majority of the studies support that physical activity 
most benefits those who are at greatest genetic risk of Alzheimer's disease. Future directions for 
research are considered with an emphasis on the need for additional funding to support this 
promising area of research. 
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Article: 
 
Alzheimer’s disease is a chronic illness that is characterized by clinical cognitive impairment and 
a relatively slow progression (4–20 years) that ultimately results in death (Alzheimer’s 
Association, 2014). Given the growing older population, the prevalence of Alzheimer’s disease 
is expected to increase dramatically in the next several decades. Because there is no known 
treatment for Alzheimer’s disease, researchers are interested in identifying strategies that might 
reduce the risk of or delay the onset of Alzheimer’s disease. One behavioral strategy that holds 
promise in this regard is physical activity. After providing a description of cognitive decline as it 
relates to advancing age, evidence will be presented relative to the potential of physical activity 
as a preventative strategy for Alzheimer’s disease. This evidence is presented from research on 
cognitively normal older adults, on cognitively impaired older adults, and relative to a genetic 
predictor of Alzheimer’s disease that may moderate the effects of physical activity on cognitive 
performance. 
 
Cognitive Decline With Advancing Age 
 
Age-related cognitive decline describes the normal change in the ability to perform cognitive 
tasks and is associated with advancing age beyond adulthood. Cross-sectional evidence supports 
that across a variety of cognitive domains including reasoning, memory, and speed of processing, 
declines in performance are evident with advancing age, with some types of cognitive 
performance beginning to show decline as soon as early adulthood (i.e., in a person’s 20s) 
(Salthouse, 1998; Schroeder & Salthouse, 2004). These changes in performance capabilities with 
advancing age are normal. However, when cognitive performance is worse than would be 
expected based upon a person’s chronological age and education level, this may then be 
considered a clinical form of cognitive impairment. When a person’s cognitive capabilities are 
worse than expected, but these decrements do not affect the person’s ability to function in daily 
life, this is considered to be a mild neurocognitive disorder (American Psychiatric Association, 
2013) and is referred to as mild cognitive impairment (MCI). When cognitive decrements are 
evident in several cognitive domains and these decrements affect daily functioning, this is 
considered to be a major neurocognitive disorder (American Psychiatric Association, 2013) and 
is referred to as dementia. The most common form of dementia, accounting for 70% of cases, is 
Alzheimer’s disease, which is characterized by impairments that become progressively worse 
over time and that are associated with the accumulation of plaques (beta-amyloid proteins) and 
tangles (tau proteins) that eventually lead to neuronal death. 
 
Alzheimer’s disease currently affects 5.2 million people in the United States, with projections 
that 7.1 million will be affected by 2025 and 13.8 million by 2050 (Alzheimer’s Association, 
2014). In addition to the large numbers of people suffering from Alzheimer’s disease, it is 
important to point out that Alzheimer’s is a particularly burdensome disease because of the slow 
progression of the illness and because of the high costs in terms of skilled care (estimated at 
$214 billion) and high value in terms of unpaid caregivers (estimated value of $220 billion) 
(Alzheimer’s Association, 2014). Given the lack of a treatment for Alzheimer’s disease, the 
identification of methods to prevent Alzheimer’s disease is an important priority for research. 
Recent trials have focused on the use of beta-amyloid antibodies, the use of a “heart-healthy” 
diet, cognitive training, and physical activity interventions. The focus of this review is on the 
potential of physical activity in reducing the risk of Alzheimer’s disease. 
 
Physical Activity and Cognitive Performance 
 
Cognitively Normal Older Adults 
 
Numerous studies have been conducted to help us understand the potential for physical activity 
to benefit cognitive performance by older adults. Etnier et al. (1997) conducted the first meta-
analytic review of the literature on physical activity and cognitive performance. At this time, the 
research in this area was relatively large and consisted of empirical studies across a broad range 
with regard to design and quality. This meta-analysis provided an inclusive review that included 
the entire body of literature at that time. However, in addition to presenting data relative to 
overall effects, the authors also provided information regarding the average effect size for 
randomized controlled trials (RCTs) (across ages, g = 0.18) and for chronic exercise studies with 
adults (45–60 years, Hedge’s g = 1.02) and older adults (60–90 years, g = 0.19). Since the 
conductance of this meta-analysis, the number of empirical studies exploring the potentially 
beneficial effect of physical activity has grown dramatically. Given the relatively large literature 
in this area, it is prudent at this time to focus our attention on the results of the strongest 
evidentiary studies, which are the RCTs and the epidemiological studies. 
 
Three meta-analytic reviews of RCTs with cognitively normal adults have been conducted, with 
two focused exclusively on older adults (Angevaren, Aufdemkampe, Verhaar, Aleman, & 
Vanhees, 2008; Colcombe & Kramer, 2003) and one including all adult ages (Smith et al., 2010). 
Colcombe and Kramer (2003) analyzed the results of 18 RCTs with older (55–80 years) adults. 
Their results indicated that exercise consistently benefited cognitive performance with an 
average overall g = 0.48. They additionally reported that the magnitude of the benefits differed 
across cognitive domains (controlled tasks: g = 0.46; spatial tasks: g = 0.43; speeded tasks: g = 
0.27), with the largest benefits evident for studies testing executive function (g = 0.68). 
Angevaren et al. (2008) reviewed the results of 11 RCTs with older (> 55 years) adults and 
reported significant positive effects for exercise that ranged from 0.26 to 0.52 and were 
dependent upon the cognitive domain and the particular comparison group that was used. Smith 
et al. (2010) included RCTs conducted with adults ≥ 18 years, so results may not be directly 
comparable to the other two reviews. However, of the 29 studies included, only seven reported 
on findings for samples that included younger adults. Their findings indicated that aerobic 
exercise resulted in significant benefits in three cognitive domains with no evidence of 
preferential benefits for executive function tasks (attention and processing speed: g = 0.16; 
executive function: g = 0.12; memory: g = 0.13). Most recently, Carvalho, Rea, Parimon, and 
Cusack (2014) conducted a systematic review of the literature for older adults (> 60 years). 
Inclusion criteria were such that RCTs had to have tested at least 30 participants and had to have 
lasted at least six months. Given these inclusion criteria, the authors reported that 9 of the 10 
RCTs yielded significant positive findings for the effects of physical activity on cognitive 
performance. In sum, empirical studies using RCT designs provide consistent support for a 
causal relationship between physical activity and the cognitive performance of cognitively 
normal older adults with effect sizes in the range of small-to-moderate. 
 
Epidemiological studies conducted in this area have used retrospective, case control, and 
prospective cohort designs. As an example of a retrospective study, Middleton, Barnes, Lui, and 
Yaffe (2010) asked 9,344 older women (M = 71.6 years) to recall their physical activity levels as 
teenagers, when they were 30 years of age, 50 years of age, and late in life. After controlling for 
a variety of potential confounds, results showed that women who reported being active at any of 
those time points had lower odds ratios for clinical impairment (OR = 0.65–0.80) than did 
women who reported being inactive at those same time points. Andel et al. (2008) conducted a 
case control study in which 3,134 older adult twin pairs were asked during middle age (M = 48.1 
years) how physically active they had been from the ages of 25–50 and then were followed for 
30 years. Results indicated that after controlling for covariates, those who had been physically 
active during young adulthood had lower risk (OR = 0.34–0.70) of being diagnosed with 
dementia 30 years later as compared with those who reported “hardly any” activity. Importantly, 
when twin pairs were compared (which allowed for the control of genetic and familial factors), 
more physically active twins had a lower risk (OR = 0.66) of dementia than their less active twin. 
Etgen et al. (2010) used a prospective cohort design to assess the influence of current physical 
activity levels on cognitive impairment two years later. Results showed that for 3,930 older 
adults (> 55 years), the risk of impairment was less (OR = 0.54–0.57) for those who were active 
compared with those who were sedentary. In the aforementioned systematic review by Carvalho 
et al. (2014), the authors also reviewed prospective studies which met their inclusion criteria by 
including at least 100 participants and lasting at least one year. The authors observed that 16 of 
16 prospective studies reported protective effects for physical activity on subsequent cognitive 
performance. In addition, evidence from five prospective studies supported a dose-response 
relationship such that greater physical activity at baseline was predictive of lesser cognitive 
decline over the years of the study. Several meta-analyses have been conducted to statistically 
summarize the results of the prospective studies (see Figure 1). All of these reviews indicate that 
physical activity reduces the risk of cognitive impairment whether defined as cognitive decline 
over time (Sofi et al., 2011), Alzheimer’s disease (Daviglus et al., 2011; Hamer & Chida, 2009), 
or dementia (Hamer & Chida, 2009), with odds ratios for the more active groups ranging from 
0.55–0.72 in comparison with the lowest physical activity group (referent, OR = 1.0). When the 
question of dose-response was addressed in the Sofi et al. (2011) review, results indicated that 
the benefits of moderate (OR = 0.65) and high (OR = 0.62) physical activity were 
indistinguishable. In sum, the epidemiological evidence is robust and supports the role of 
physical activity in protecting against cognitive decline and clinical cognitive impairments in 
advancing age. 
 
 
Figure 1. Odds ratios for cognitive impairment as reported in meta-analytic reviews of 
prospective studies. PA = physical activity; AD = Alzheimer’s disease; NR = not reported 
number of. 
 
Adults With Cognitive Impairment 
 
Research with older adults who are already experiencing cognitive impairment is also somewhat 
promising. Four meta-analytic or systematic reviews have been conducted in this area with two 
focusing on MCI (Gates, Fiatarone Singh, Sachdev, & Valenzuela, 2013; Wang et al., 2014), one 
focusing on dementia (Forbes, Thiessen, Blake, Forbes, & Forbes, 2013), and one reporting 
separately on studies on participants with MCI and on studies with participants with dementia 
(Ohman, Savikko, Strandberg, & Pitkala, 2014). 
 
Mild Cognitive Impairment. Gates et al. (2013) reviewed studies with adults over 65 years who 
had been diagnosed with MCI or who had scores on the Mini-Mental State Exam (MMSE) that 
were between 24–28. From 14 RCTs, they reported that only 8% of cognitive outcomes that 
were assessed yielded statistically significant differences between treatment groups. They further 
reported that the overall effect size was negligible for measures of executive function, memory, 
and information processing, and was small (ES = 0.17) for verbal fluency. Based upon their 
findings, Gates et al. (2013) concluded that there was not strong evidence supporting the benefits 
of exercise for persons with MCI. 
 
Wang et al. (2014) meta-analytically reviewed the findings of seven RCTs with participants with 
MCI. Their results indicated that significant benefits of exercise were evident for measures of 
global cognition (SMD = 0.25), but were not observed in any specific cognitive domains 
(executive function, memory). Important direction might be provided by the results of moderator 
analyses, which indicated that for global cognition, studies using shorter interventions (< 12 
months) resulted in larger effects (SMD = 0.43) than those using longer interventions (≥12 
months), and that studies using aerobic exercise yielded larger effects (SMD = 0.35) than studies 
using nonaerobic exercise (SMD = 0.16). Importantly, effects were larger for higher quality 
studies (SMD = 0.27) than for lower quality studies (SMD = –0.01), suggesting that more 
rigorous studies yield stronger results. In summarizing their findings, Wang et al. (2014) 
concluded that exercise shows some potential for benefiting global cognition in MCI patients and 
urged future research to focus on identifying the best mode of exercise and the optimal intensity 
of exercise to produce cognitive benefits. 
 
Ohman et al. (2014) identified RCTs exploring the effects of exercise on MCI (n = 8) and 
performed a box count of significant findings based upon whether the outcome was global 
cognition or performance in a specific cognitive domain. Results showed that findings for global 
cognition and attention were most promising with positive effects observed in three of five 
studies and four of four studies, respectively. Results were also somewhat promising for 
executive function, with significant differences reported in three of six studies. Based upon the 
evidence presented in their review, Ohman et al. (2014) concluded that for MCI, there was 
evidence of good quality supporting positive effects for cognition. 
 
One limitation with regard to drawing a consensus from these reviews is that the conclusions 
drawn and the levels of enthusiasm for these conclusions are quite different. Based upon their 
observed results, Gates et al. (2013) were relatively pessimistic about the value of physical 
activity for cognitive benefits in persons with MCI whereas by contrast Ohman et al. (2014) and 
Wang et al. (2014) were more enthusiastic. One reason for the different conclusions may relate 
to the studies included (see Figure 2a). Ohman et al. and Wang et al. had seven studies in 
common. By contrast, the Gates et al. review only shared six studies with the other two reviews 
and there were an additional seven studies that were unique to the Gates et al. review. It is 
important to point out that a limitation consistently identified by the reviewers is the 
heterogeneity with regard to the exercise interventions, control groups, cognitive outcomes, and 
specific cognitive abilities of the samples. Heterogeneity in these first three aspects is a common 
limitation of research in the area of exercise and cognitive performance, but in the case of the 
literature on MCI, our ability to synthesize the literature is further exacerbated by the lack of 
consistency in the definition of MCI. Thus, despite the efforts of the reviewers to include studies 
on MCI, the individual studies included may in fact be focused on participants who differ in 
terms of the subtypes of MCI. Given that MCI represents a transitional state between cognitive 
normality and dementia, this clearly presents a challenge in synthesizing the evidence, and 
research in this area will benefit from adopting a standard clinical definition of MCI so that more 
homogeneous samples can be observed. 
 
 
Figure 2. Comparison of studies included in the reviews on mild cognitive impairment. (a) 
Overlap among studies included in the reviews. (b) Mode of exercise used in the studies that 
were shared as compared with the studies unique to Gates et al. (2013). 
 
Another variable that may have impacted the different conclusions drawn in these reviews is that 
there was heterogeneity in the mode of exercise used in the included studies (see Figure 2b). Of 
the six shared studies, four used aerobic interventions, one used a Tai Chi intervention, and one 
used a mixed intervention including an aerobic component. By contrast, in the seven studies that 
were only included in the Gates et al. (2013) review, two used aerobic interventions, two used 
mixed interventions including an aerobic component, and three used interventions without an 
aerobic component. Given the suggestion by Wang et al. (2014) that the effects of exercise on 
cognitive performance may depend on both the cognitive task and the modality of the exercise, it 
is possible that the inclusion of a more heterogeneous group of studies with regard to exercise 
modality explains the less positive results reported by Gates et al. (2013). That being said, this is 
only one possibility as there are numerous other variables (such as the aforementioned 
differences in MCI definitions) that may also explain the heterogeneous conclusions. 
 
Dementia. In their review, Ohman et al. (2014) also included RCTs exploring the effects of 
exercise on dementia (n = 14). These studies were described as being of lower quality than the 
studies on MCI and results were not as promising. Results showed that in the two studies testing 
effects for global cognition there were no beneficial effects. By contrast, studies testing the 
effects on executive function did yield positive effects (3 of 4 studies), however these positive 
effects were only reported in studies described as being of low quality and were not evident in 
the study deemed to be of moderate quality. In studies testing the effects on measures of 
memory, three studies looking at delayed recall, six studies looking at working memory, and 
three studies examining declarative memory all yielded nonsignificant effects. Hence, the 
authors concluded that evidence supporting beneficial effects of exercise for persons with 
dementia are not promising, with positive effects only being reported in studies of poor 
methodological quality. 
 
Forbes et al. (2013) also meta-analytically reviewed studies focused on persons with dementia. 
They included 14 RCTs focused on cognitive outcomes and reported that exercise had a 
significant positive effect on cognitive performance (SMD = 0.55). Given their findings, these 
authors concluded that exercise can improve cognitive performance by persons with dementia 
and recommended that health-care providers and caregivers should “feel confident in promoting 
exercise among this population” (p. 19) because of the prospect of slowing patients’ cognitive 
decline. 
 
In considering the findings of the reviews on exercise in patients with dementia, it is not clear 
why the conclusions are so dramatically different. However, it is important to again point out 
that the two reviews did not include the exact same literature. There were eight studies that were 
included in both reviews, but there were an additional six unique studies to each review (see 
Figure 3). Again, it is likely that the different conclusions are thus reflective of the heterogeneity 
in experimental designs and cognitive measures of studies included in these reviews. 
 
 
Figure 3. Comparison of studies included in the reviews on dementia. 
 
Summary. In sum, results from studies exploring the potential cognitive benefits of physical 
activity for cognitively impaired older adults are mixed, but there is some evidence of beneficial 
effects with reported effect sizes ranging from small to moderate. It is critically important that 
additional research be conducted to improve our understanding of how to optimally design 
exercise programs to ensure that cognitive benefits result for persons suffering from clinical 
cognitive impairment. 
 
Moderators 
 
One interesting approach to understanding the role of physical activity in the prevention of 
dementia is to explore the moderating role of the apolipoprotein E (APOE) genotype on the 
relationship between physical activity and cognitive performance. APOE is a susceptibility gene 
for Alzheimer’s disease with the e4 allele being predictive of increased risk. In particular, 
persons who carry one copy of the e4 allele (heterozygotes) are at 2–3 times greater risk and 
persons who carry two copies (homozygotes) are at 8–15 times greater risk of Alzheimer’s 
disease in comparison with persons with no copies of the e4 allele (noncarriers) (Corder et al., 
1993; Farrer et al., 1997). Studies exploring the role of APOE genotype as a moderator have used 
correlational and prospective designs. 
 
Etnier et al. (2007) assessed aerobic fitness and cognitive performance in cognitively normal 
older (ages 51–77 years) women. Their results showed that the relationship between aerobic 
fitness and cognitive performance was nonsignificant for the noncarriers and heterozygotes, but 
was significant and explained 33% of the variance for the homozygotes. In particular, higher 
levels of fitness were predictive of better performance on three measures of memory and one 
measure of attention for the homozygotes. Deeny et al. (2008) measured physical activity and 
working memory performance in older (50–70 years) cognitively normal men and women. 
Similar to the findings from Etnier et al., results indicated that the relationship between physical 
activity and cognitive performance was significant only for the e4 carriers. 
 
Several prospective studies have been conducted to test the moderating effect of APOE on the 
effects of baseline physical activity on subsequent cognitive decline (see Figure 4 for results 
from each study). Interestingly, the results of these studies are not consistent. Schuit, Feskens, 
Launer, and Kromhout (2001) reported findings from the Zutphen Elderly Study, in which 
physical activity and cognitive performance were assessed in older (65–84 years) men at baseline 
and then cognitive performance was assessed again approximately three years later. Although 
they did not statistically test the interaction term for APOE 3 physical activity, they did present 
results separately for noncarriers and carriers. These results indicated that physical activity 
significantly reduced the risk of cognitive decline (operationalized as a ≥ 3 point decline on the 
MMSE) for the carriers (OR = 3.7), but had no benefit for the noncarriers. Niti, Yap, Kua, Tan, 
and Ng (2008) tested participants in the Singapore Longitudinal Aging Study at baseline and 
after a one-year follow-up. They reported that APOE genotype significantly moderated the 
effects of leisure activity on cognitive decline (operationalized as a ≥ 1 point decline on the 
MMSE) such that beneficial effects were greater for carriers than noncarriers, but were evident 
for both (carriers: OR = 0.36–0.37; noncarriers: OR = 0.65–0.68). Podewils et al. (2005) assessed 
physical activity in nondemented older adults (> 65 years) enrolled in the Cardiovascular Health 
Study at baseline and determined whether they met criteria for dementia approximately 5.4 years 
later. Results of this study supported a moderating effect of APOE genotype on the effects of 
physical activity on dementia risk, but in contrast to the previous studies, the effects showed that 
the benefits of physical activity were limited to the APOE noncarriers. 
 
 
Figure 4. Results from prospective studies testing the moderating effects of APOE genotype on 
the effects of baseline physical activity on future risk of clinical impairment. Note. Confidence 
interval for Schuit et al. (2001) sedentary APOE e4 carriers = [1.1-12.9]; Ref = referent group. 
 
 
Figure 5. Results from prospective studies reporting on data from the Cardiovascular Risk 
Factors, Aging and Dementia (CAIDE) study. Note. Confidence interval for Kivipelto et al. 
(2008) sedentary APOE e4 carriers = [2.31-13.23] and for active APOE e4 carriers = [0.81-6.49]. 
Confidence interval for Tolppanen et al. (2014) low active APOE e4 non-carriers = [1.12-3.06]; 
Ref = referent group. 
 
Three prospective studies reported on participants enrolled in the Cardiovascular Risk Factors, 
Aging and Dementia (CAIDE) study in which leisure-time physical activity was assessed at 
baseline, and dementia and Alzheimer’s disease were assessed at subsequent examinations (see 
Figure 5 for results from each publication). Rovio et al. (2005) and Kivipelto et al. (2008) 
reported on the findings from the first reexamination visit, which occurred approximately 21 
years after baseline testing. Both Rovio et al. (2005) and Kivipelto et al. (2008) reported 
nonsignificant interaction terms for APOE on physical activity for the outcome of dementia, but 
then provided the stratified findings for the carriers and noncarriers. Both Rovio et al. (2005) and 
Kivipelto et al. (2008) reported that protective effects of physical activity for dementia are only 
evident for the APOE e4 carriers. Relative to the outcome of Alzheimer’s disease, Rovio et al. 
(2005) reported a significant interaction term with results indicating that the risk of Alzheimer’s 
disease is significantly reduced for active carriers but that there is no effect of physical activity 
for noncarriers. Kivipelto et al. (2008) also reported that associations for Alzheimer’s disease 
were stronger, but they do not share those results in the publication. Tolppanen et al. (2014) 
collapsed together the data from the first and the second (approximately 7–10 additional years 
later) reexamination visits for CAIDE participants. Despite the larger sample size, the results of 
this study also indicated that the effects were not significantly moderated by APOE carrier status. 
However, the authors did report relationships between physical activity and dementia and 
reported that the risk of dementia was lowest for the high active group regardless of APOE 
carrier status. 
 
Clearly it is difficult to bring this body of literature to consensus due to the relatively small 
number of studies, the wide range of follow-up times, the unique samples, and the variety of 
measures used for physical activity and for cognitive outcomes. In considering the reasons for 
the mixed results reported in the prospective studies, it is also perhaps important to mention that 
the decision of how to categorize the e2/e4 genotypes may influence the findings. As previously 
mentioned, the e2 allele is protective against Alzheimer’s disease, thus the e2/e4 genotype 
consists of one protective allele and one allele that is associated with an increased risk of 
Alzheimer’s disease. The e2/e4 genotype makes up approximately 3% of the population (McKay 
et al., 2011), and although studies are limited there is evidence that this group is at the same 
relatively low risk of Alzheimer’s disease as are persons with the e3/e3 genotype (Corder et al., 
1994; Corder et al., 1993). Thus, it seems that persons who are e2/e4 should be categorized as 
noncarriers. However, the e2/e4 genotype was included with the carriers in the Podewils et al. 
(2005) study and in the Niti et al. (2008) study, and how persons of this genotype were 
categorized is not explicitly stated in the other prospective studies. Hence, this is an additional 
source of variation that may have contributed to the heterogeneity of the results. That being said, 
both of the cross-sectional studies and four of the six prospective studies provide results 
supportive of the benefits of physical activity being most evident for persons at greatest genetic 
risk for Alzheimer’s disease. If future evidence supports this interpretation of the current findings 
(i.e., that physical activity is most beneficial for those at greatest genetic risk for Alzheimer’s 
disease), this will be critically important because it will provide additional evidence that physical 
activity may be an effective behavioral intervention in the prevention of Alzheimer’s disease. 
 
Summary and Conclusions 
 
Overall, the extant literature clearly shows that regular participation in physical activity benefits 
cognitive performance for cognitively normal older adults, and there is some evidence that these 
benefits can also be obtained by cognitively impaired older adults. The literature also 
consistently shows that the APOE genotype moderates the relationship between physical activity 
and cognitive performance, but positive relationships have been observed for both carriers and 
noncarriers so future research will be necessary to improve our understanding of this effect. One 
important direction for future research is to consider other genetic predictors of Alzheimer’s 
disease, which may interact with the APOE genotype in influencing the relationship between 
physical activity and cognitive performance. In addition, future research focused on mechanisms 
of the effects will certainly contribute to our ability to understand how to best implement a 
physical activity intervention with a goal of benefiting cognitive performance and delaying the 
experience of Alzheimer’s disease. This is a critical direction for research as Brookmeyer, Gray, 
and Kawas (1998) reported that a treatment that delays the incidence of Alzheimer’s disease by 
five years would reduce the incidence by 50%. Further, Barnes and Yaffe (2011) reported that a 
reduction in physical inactivity levels by 10% would decrease the number of people in the 
United States with Alzheimer’s disease by 90,000 and a reduction in physical inactivity levels by 
25% would result in a decrease of those with Alzheimer’s by 232,000. In fact, their data indicate 
that reductions in physical inactivity would have a greater impact on the incidence of 
Alzheimer’s disease than would changes in other modifiable factors such as hypertension, 
obesity, and smoking. Hence, it is critical for future research to further our understanding of how 
to use physical activity interventions to slow age-related cognitive decline and lessen the risk of 
MCI and Alzheimer’s disease. 
 
As a final comment, I would like to make a plea for funding agencies to commit additional 
resources to advancing our understanding of the potential role of exercise in mitigating age-
related cognitive decline and reducing the risk of clinical cognitive impairment. In conducting 
this review of the literature, I was struck by the frequency with which the authors of reviews 
concluded that the literature is limited by the poor quality of the research and by the lack of 
sufficiently powered clinical trials. Although this is certainly an accurate characterization of the 
literature, I believe it is important to emphasize that this is not a reflection of the quality of the 
researchers working in this area, but rather is an indication of the lack of financial support 
directed toward understanding the effects of exercise on cognition. 
 
As an example of the lack of financial support in this area, it seems important to point out that 
the largest funding agency of health research in the United States (the National Institutes of 
Health [NIH]) has historically demonstrated a lack of interest in research on exercise and 
cognitive performance. This is evidenced by the historic lack of program announcements (PAs) 
and requests for applications (RFAs) targeting this topic and by the general failure to include 
persons with exercise expertise on scientific review groups. There have been encouraging recent 
signs that there is now interest in exploring the benefits of physical activity for cognitive 
performance based upon the occasional RFAs that have explicitly encouraged applications 
focused on the effects of exercise on cognitive outcomes (e.g., RFA-AG-09–009 and RFA-AG-
14–016). However, these RFAs were only offered for one cycle of funding and a current search 
of active RFAs and PAs available from the NIH indicated that 0 records were returned when 
exercise was entered as a keyword (search conducted on 10/22/2014). When physical activity 
was used as a keyword, 14 records were retrieved, with six of these providing funding through 
smaller funding mechanisms (R21, R03, R33) in parallel to the same call using a larger funding 
mechanism (R01). Hence, there were eight unique RFAs or PAs relative to physical activity. Of 
these eight, the focus is largely on the prevention of overweight and obesity (RFA-13–153, PA-
13–110, PA-13–100, PAR-12–257, PAR-12–228), with other calls focused on physical activity 
assessment (RFA-AG-15–015, PAR-12–198) and physical activity promotion (PAR-14–315). 
Although these are clearly important directions for physical activity research, it is inexplicable 
that there is not a single active funding opportunity through the NIH supporting research on 
exercise (or physical activity) and cognitive performance. Given the evidence supporting the 
potential benefits of exercise for cognition and the current and projected personal and public 
health impact of age-related cognitive decline and of Alzheimer’s disease in particular, it is 
critical that funding agencies provide adequate resources for well-designed sufficiently powered 
RCTs to be conducted in this area of research and that they place persons with exercise expertise 
on scientific review panels to ensure that the exercise programs are well-designed and logical 
based upon the extant literature. 
 
This manuscript was based a lecture given at the 2014 annual meeting of the National Academy 
for Kinesiology, Austin, TX. 
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